Business Wire

First-to-market, one-step process automates and simplifies fixture-related filings

MINNEAPOLIS--(BUSINESS WIRE)-- Wolters Kluwer Compliance Solutions’ introduction of iLien ResiFixture™ is playing a critical step in helping lenders safeguard their interests for loans associated with fixtures physically attached to a residential property.

“iLien ResiFixture provides residential lenders a simpler path to securing their fixture-related assets,” notes ... (continue reading...)

– The leading high-growth retailer opens its 228th store in the U.S., offering the biggest in-stock hard-surface flooring selections at everyday low prices for homeowners and construction professionals –

BROOKLYN, N.Y.--(BUSINESS WIRE)-- Floor & Decor (NYSE: FND), the leading high-growth retailer specializing in hard-surface flooring for homeowners and professionals, has announced its first-ever New York City store, opening to the public on May 6, 2024.... (continue reading...)

SAN DIEGO--(BUSINESS WIRE)-- Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced the publication of its TORREY Phase 2 study manuscript in the Lancet Respiratory Medicine journal. The paper, titled "Seralutinib in Adults with... (continue reading...)

MALVERN, Pa.--(BUSINESS WIRE)-- As a key housing partner to the U.S. Navy, Balfour Beatty Communities, is pleased to announce the completion of two large-scale projects within the Company’s Navy housing portfolio in direct support of the Navy’s energy resilience and climate goals.

In a multi-year project initiated in 2021, Balfour Beatty Communities developed a project for the installation of rooftop solar systems across the Navy housing communities located at... (continue reading...)

Conference Call and Webcast Scheduled for Monday, May 13, 2024, at 10:00AM ET

PRINCETON, N.J.--(BUSINESS WIRE)-- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report 2024 first quarter financial results on Monday, May 13, 2024, prior to the open of the stock market. The announcement will be followed by a live audio... (continue reading...)